These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32291442)
21. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Lee HH; Lee YJ; Lin CY Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125 [TBL] [Abstract][Full Text] [Related]
22. Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency. Lee HH; Lee YJ; Chao MC Anal Biochem; 2010 Apr; 399(2):293-8. PubMed ID: 19961824 [TBL] [Abstract][Full Text] [Related]
23. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Chen W; Kim MS; Shanbhag S; Arai A; VanRyzin C; McDonnell NB; Merke DP Am J Med Genet A; 2009 Dec; 149A(12):2803-8. PubMed ID: 19921645 [TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency. Ma D; Chen Y; Sun Y; Yang B; Cheng J; Huang M; Zhang J; Zhang J; Hu P; Lin Y; Jiang T; Xu Z Clin Biochem; 2014 Apr; 47(6):455-63. PubMed ID: 24503005 [TBL] [Abstract][Full Text] [Related]
25. Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients. Demirdas S; Dulfer E; Robert L; Kempers M; van Beek D; Micha D; van Engelen BG; Hamel B; Schalkwijk J; Loeys B; Maugeri A; Voermans NC Clin Genet; 2017 Mar; 91(3):411-425. PubMed ID: 27582382 [TBL] [Abstract][Full Text] [Related]
26. Long-read sequencing solves complex structure of CYP21A2 in a large 21-hydroxylase deficiency cohort. Wang R; Luo X; Sun Y; Liang L; Mao A; Lu D; Zhang K; Yang Y; Sun Y; Sun M; Han L; Zhang H; Gu X; Qiu W; Yu Y J Clin Endocrinol Metab; 2024 Jul; ():. PubMed ID: 39049755 [TBL] [Abstract][Full Text] [Related]
27. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion. Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489 [TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of the new clinical entity associated with congenital adrenal hyperplasia: the CAH-X syndrome in the Spanish population. Figueras LM; Pacheco RM; González DG; Domènech MA; Zubicaray BE Adv Lab Med; 2023 Sep; 4(3):258-267. PubMed ID: 38075167 [TBL] [Abstract][Full Text] [Related]
30. Diversity of the CYP21P-like gene in CYP21 deficiency. Lee HH DNA Cell Biol; 2005 Jan; 24(1):1-9. PubMed ID: 15684714 [TBL] [Abstract][Full Text] [Related]
31. Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene. Leccese A; Longo V; Dimatteo C; De Girolamo G; Trunzo R; D'Andrea G; Bafunno V; Margaglione M; Santacroce R Clin Chim Acta; 2014 Nov; 437():48-51. PubMed ID: 25025300 [TBL] [Abstract][Full Text] [Related]
32. Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome. Kim JH; Kim GH; Yoo HW; Choi JH Ann Pediatr Endocrinol Metab; 2023 Jun; 28(2):77-86. PubMed ID: 37401054 [TBL] [Abstract][Full Text] [Related]
33. Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency. Lee HH; Lee YJ; Wang YM; Chao HT; Niu DM; Chao MC; Tsai FJ; Lo FS; Lin SJ Mol Genet Metab; 2008 Apr; 93(4):450-7. PubMed ID: 18039588 [TBL] [Abstract][Full Text] [Related]
34. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569 [TBL] [Abstract][Full Text] [Related]
35. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency. Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666 [TBL] [Abstract][Full Text] [Related]
36. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880 [TBL] [Abstract][Full Text] [Related]
37. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions. Koppens PF; Hoogenboezem T; Degenhart HJ Hum Mol Genet; 2002 Oct; 11(21):2581-90. PubMed ID: 12354783 [TBL] [Abstract][Full Text] [Related]
38. [Analysis of copy number variation of Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511 [No Abstract] [Full Text] [Related]
39. Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome. Morissette R; Merke DP; McDonnell NB Eur J Med Genet; 2014 Feb; 57(2-3):95-102. PubMed ID: 24380766 [TBL] [Abstract][Full Text] [Related]
40. Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events. Petersen JW; Douglas JY Med Hypotheses; 2013 Sep; 81(3):443-7. PubMed ID: 23830591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]